Home The Word Brain My Amedeo FAQ Privacy About   


Chinese Coaching

Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.


  Cervical Cancer

  Free Subscription


15.12.2025

1 3 Biotech
1 Am J Clin Oncol
1 Anal Bioanal Chem
1 Anticancer Drugs
1 Biomed Res Int
4 BMC Public Health
3 BMC Womens Health
1 BMJ Case Rep
1 BMJ Glob Health
1 Brachytherapy
1 Cancer Manag Res
1 Cancer Med
1 Cancer Res
1 Cancer Treat Res Commun
1 Cell Death Differ
1 Cell Death Discov
1 Clin Nucl Med
1 Cureus
2 Cytopathology
1 Data Brief
1 Diagn Microbiol Infect Dis
1 Diagnostics (Basel)
1 Digit Health
3 Discov Oncol
1 Eur J Cancer Prev
1 Exp Ther Med
1 Expert Rev Pharmacoecon Outcomes Res
1 Food Chem Toxicol
1 Front Immunol
1 Front Med (Lausanne)
4 Front Oncol
1 Front Public Health
5 Gynecol Oncol
1 Health Educ Res
1 Hell J Nucl Med
2 Hum Vaccin Immunother
1 Indian J Pathol Microbiol
1 Inflamm Res
1 Int J Gynaecol Obstet
2 Int J Gynecol Cancer
1 Int J Oncol
2 Int J Surg
1 Iran J Public Health
2 J Am Soc Cytopathol
1 J Cancer Educ
1 J Coll Physicians Surg Pak
1 J Control Release
1 J Ethnopharmacol
1 J Gynecol Oncol
4 J Med Virol
1 J Natl Cancer Inst
1 J Obstet Gynaecol
1 J Pathol
1 JAMA
1 JAMA Netw Open
1 JCO Glob Oncol
1 JMIR Public Health Surveill
1 Kaohsiung J Med Sci
1 Kyobu Geka
1 Lancet Digit Health
1 Lancet Glob Health
2 Med
1 Med Eng Phys
1 Medicine (Baltimore)
1 Molecules
1 NMR Biomed
1 NPJ Precis Oncol
1 Nucl Med Commun
1 O G Open
1 Obstet Gynecol
1 Obstet Gynecol Surv
2 Oncologist
1 Oncology
1 Oncology (Williston Park)
2 PLoS One
1 Pract Radiat Oncol
1 Prev Med
1 Quant Imaging Med Surg
1 Regen Biomater
1 Rom J Morphol Embryol
1 RSC Adv
1 Scand J Prim Health Care
2 Sci Rep
1 Semin Cancer Biol
1 Talanta
1 Technol Cancer Res Treat
1 Tissue Cell
1 Transl Cancer Res
4 Vaccine
2 Virol J
3 World J Psychiatry
1 World J Surg Oncol
2 Zhonghua Bing Li Xue Za Zhi


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    3 Biotech

  1. ANAND RAJ LFA, Shreya S, Rithika G, Namasivayam SKR, et al
    Multi-functional zinc oxide nanoparticles (ZnONps inspired from Myristica Fragrans seed extract against cervical Cancer, pyogenic bacteria and inflammatory response. a promising potential of ZnONps in cancer nanotherapy, infection control and inflamma
    3 Biotech. 2026;16:21.
    PubMed         Abstract available


    Am J Clin Oncol

  2. SINHA R, Portmann-Baracco A, Gorman AR, Stock EC, et al
    Impact of Interruptions in Chemotherapy on Survival for Patients With Metastatic or Recurrent Cervical Cancer.
    Am J Clin Oncol. 2025 Dec 8. doi: 10.1097/COC.0000000000001279.
    PubMed         Abstract available


    Anal Bioanal Chem

  3. SOUZA APO, Lima LA, Ferreira PAB, Maux JML, et al
    An electrochemical immunosensor for intraepithelial neoplasia in cervicovaginal lavage using a fullerene-TCNQ platform for p16 detection.
    Anal Bioanal Chem. 2025;417:6933-6946.
    PubMed         Abstract available


    Anticancer Drugs

  4. DAI J, Yang R, Cun Y, Zhang X, et al
    Precision design of an HLA-I-targeted multiepitope vaccine against human papillomavirus 16 oncoproteins E6/E7: integrated immunoinformatic and immunogenicity profiling.
    Anticancer Drugs. 2026;37:58-66.
    PubMed         Abstract available


    Biomed Res Int

  5. KLUTSE J, Tay YA, Attoh DA, Gyekye EF, et al
    Cervical Cancer in Women With HIV: A Call to Action for Equitable Prevention in Low- and Middle-Income Countries.
    Biomed Res Int. 2025;2025:1711050.
    PubMed         Abstract available


    BMC Public Health

  6. KHUNTSARIA I, Gachechiladze K, Lipartia E, Kobulashvili T, et al
    HPV vaccination and cervical cancer control in Georgia: evidence and projections.
    BMC Public Health. 2025 Dec 13. doi: 10.1186/s12889-025-25958.
    PubMed        

  7. LI Y, Zheng K, Xu Q, Xie L, et al
    Global, regional, and national epidemiology of cervical cancer in elderly women from 1990 to 2021 and its prediction to 2035.
    BMC Public Health. 2025 Dec 13. doi: 10.1186/s12889-025-25029.
    PubMed        

  8. MOSQUERA I, Chandran A, Rol ML, Mesmin Olivier AY, et al
    Assessment of barriers to the cervical cancer continuum and existing interventions in 5 African countries.
    BMC Public Health. 2025 Dec 4. doi: 10.1186/s12889-025-25733.
    PubMed        

  9. ZHANG L, Zhang Y, Wang X, Tang C, et al
    Is the domestic bivalent HPV vaccine cost-effective compared with quadrivalent or nine-valent HPV vaccines in the context of cervical cancer screening? A modeling study.
    BMC Public Health. 2025 Dec 4. doi: 10.1186/s12889-025-25797.
    PubMed         Abstract available


    BMC Womens Health

  10. NSAFUL J, Sefogah PE, Dedey F, Nartey E, et al
    Cervical cancer knowledge among high school students in Southern Ghana.
    BMC Womens Health. 2025 Dec 10. doi: 10.1186/s12905-025-04171.
    PubMed         Abstract available

  11. RUSATIRA JC, Uwimana JB, Rutagumba D, Byiringiro S, et al
    Investigating the mental health burden amongst breast and cervical cancer patients in Rwanda using a modified self-reported questionnaire for mental health screening (SRQ-20): A validation study.
    BMC Womens Health. 2025 Dec 8. doi: 10.1186/s12905-025-04207.
    PubMed        

  12. BERZA N, Stars I, Zodzika J, Kivite-Urtane A, et al
    Understanding hesitancy: barriers to HR-HPV self-sampling among women at high risk for cervical cancer in Latvia.
    BMC Womens Health. 2025 Dec 7. doi: 10.1186/s12905-025-04205.
    PubMed         Abstract available


    BMJ Case Rep

  13. KUENGHAKIT S, Newnham A, Ismail M
    Expectant management of missed miscarriage in a post-trachelectomy patient with permanent cervical cerclage.
    BMJ Case Rep. 2025;18:e270092.
    PubMed         Abstract available


    BMJ Glob Health

  14. GOMES MADEIRA C, Marotta C, Ditter AG, Raviglione MCB, et al
    Participation in cervical cancer screening among migrants and non-migrants in primary healthcare in Lisbon: a register-based study.
    BMJ Glob Health. 2025;10:e019061.
    PubMed         Abstract available


    Brachytherapy

  15. SARGAZI V, Naseri S, Gholamhosseinian H, Momennezhad M, et al
    Applicator reconstruction in cervical cancer brachytherapy: A systematic review of current methods, challenges, and AI-driven future directions.
    Brachytherapy. 2025 Dec 3:S1538-4721(25)00325.
    PubMed         Abstract available


    Cancer Manag Res

  16. LIU M, Wang J, Luo L
    Self-Compassion Mediates the Relationship Between Social Support and Quality of Life in Cervical Cancer Patients: A Cross-Sectional Study.
    Cancer Manag Res. 2025;17:3039-3048.
    PubMed         Abstract available


    Cancer Med

  17. YU M, Ni M, Xu F, Fang C, et al
    Overexpressed CD24 and CD47 Indicate a Worse Prognosis in Cervical Cancer.
    Cancer Med. 2025;14:e71443.
    PubMed         Abstract available


    Cancer Res

  18. WAN T, Deng T, Peng X, Cai G, et al
    Comprehensive Multi-Omic Characterization of Perineural Invasion in Cervical Cancer Reveals Diagnostic Markers, Molecular Drivers, and Therapeutic Strategies.
    Cancer Res. 2025 Dec 11. doi: 10.1158/0008-5472.CAN-25-0149.
    PubMed         Abstract available


    Cancer Treat Res Commun

  19. SHENG J, Luan J, Zhao Y, Xing Y, et al
    Clonal origins and divergent evolutionary relationships of synchronous multiple malignant neoplasms in gynecology revealed by next-generation sequencing.
    Cancer Treat Res Commun. 2025;45:101013.
    PubMed         Abstract available


    Cell Death Differ

  20. YUAN L, Jiang H, Xia M, Wen W, et al
    P4HA3 drives cervical cancer lymphatic metastasis by facilitating ACLY-mediated ferroptosis resistance.
    Cell Death Differ. 2025 Dec 11. doi: 10.1038/s41418-025-01644.
    PubMed         Abstract available


    Cell Death Discov

  21. LIU L, Han Z, Qian Q, Liu X, et al
    Unraveling the mechanisms of LncRNAs in cervical cancer: a comprehensive review.
    Cell Death Discov. 2025 Dec 13. doi: 10.1038/s41420-025-02902.
    PubMed         Abstract available


    Clin Nucl Med

  22. KIBAR A, Sahin OE, Sayman HB
    FDG PET/CT Image of Extrarenal Wilms Tumor of Cervix.
    Clin Nucl Med. 2025 May 8. doi: 10.1097/RLU.0000000000005941.
    PubMed         Abstract available


    Cureus

  23. MABUCHI S, Komura N, Wakimoto Y, Ueda T, et al
    Salvage Radical Hysterectomy for Recurrent Cervical Cancer in a Previously Irradiated Field Using the hinotori Surgical Robot System: A Case Report.
    Cureus. 2025;17:e96395.
    PubMed         Abstract available


    Cytopathology

  24. CHONG Y, Bychkov A
    Commercially Available Artificial Intelligence Solutions for Gynaecologic Cytology Screening and Their Integration Into Clinical Workflow.
    Cytopathology. 2026;37:24-44.
    PubMed         Abstract available

  25. TRESSERRA F, Dinares C, Luque O, Serra M, et al
    Intercenter Study of Interobserver Variability With Optical and Digital Imaging in Cervicovaginal Cytology. Simulation of a Quality Control Program.
    Cytopathology. 2026;37:45-52.
    PubMed         Abstract available


    Data Brief

  26. OCAMPO-LOPEZ-ESCALERA J, Rosete-Aguilar M, Ochoa-Diaz-Lopez H, Sanchez-Chino XM, et al
    CPSMI2025: A curated dataset of conventional Pap smear microscopy images for deep learning-based cervical cancer screening.
    Data Brief. 2025;63:112272.
    PubMed         Abstract available


    Diagn Microbiol Infect Dis

  27. ERDIREN N, Atik TK, Turan G, Sener AG, et al
    High-risk HPV genotype distribution and prevalence in cervical swabs from Western Turkey.
    Diagn Microbiol Infect Dis. 2026;114:117132.
    PubMed         Abstract available


    Diagnostics (Basel)

  28. NASERI P, Shahbazi-Gahrouei D, Rajaei-Nejad S
    Evaluation of Model Performance and Clinical Usefulness in Automated Rectal Segmentation in CT for Prostate and Cervical Cancer.
    Diagnostics (Basel). 2025;15:3090.
    PubMed         Abstract available


    Digit Health

  29. SU L, Yao J, Ai X, Xu R, et al
    Short videos platforms as sources of health information about cervical cancer screening: A content and quality analysis.
    Digit Health. 2025;11:20552076251404516.
    PubMed         Abstract available


    Discov Oncol

  30. NI L, Li L, Li D, Ding Y, et al
    A dosimetric correlation between the bladder filling volume and its effects on radiation dose during high-dose-rate intracavitary brachytherapy in patients with cervical cancer.
    Discov Oncol. 2025 Dec 12. doi: 10.1007/s12672-025-04254.
    PubMed         Abstract available

  31. DE OLIVEIRA MC, Fortunato GM, da Silva PR, Pacheco BLB, et al
    CTLA4 genetic variants influence immune regulation and susceptibility of HPV associated cervical cancer.
    Discov Oncol. 2025 Dec 10. doi: 10.1007/s12672-025-04179.
    PubMed         Abstract available

  32. GUO L, Zhang Q
    Identification of MFSD3 as a potential prognostic biomarker of cervical cancer.
    Discov Oncol. 2025 Dec 6. doi: 10.1007/s12672-025-04184.
    PubMed         Abstract available


    Eur J Cancer Prev

  33. TAO L, Zhou D, Luo M, Duan Z, et al
    The relationship between atypical glandular cells and malignancy risk: a retrospective single-center study.
    Eur J Cancer Prev. 2026;35:21-28.
    PubMed         Abstract available


    Exp Ther Med

  34. MO L, Liang R, Wang X, Xiao Z, et al
    Effect of enhanced recovery after surgery-based perioperative nursing on postoperative pain and recovery in patients with cervical cancer: A retrospective cohort study.
    Exp Ther Med. 2025;31:30.
    PubMed         Abstract available


    Expert Rev Pharmacoecon Outcomes Res

  35. DEL PILAR BRICENO-CASADO M, Sanchez Vegas A, Alegre-Del-Rey EJ, Olry de Labry Lima A, et al
    Cost-effectiveness of second- or third-line treatment with tisotumab vedotin for metastatic or recurrent cervical cancer.
    Expert Rev Pharmacoecon Outcomes Res. 2025.
    PubMed         Abstract available


    Food Chem Toxicol

  36. LI X, Li H
    Assessing the role of bisphenol A in female reproductive cancers using network toxicology, molecular dynamics, and preliminary experimental validation.
    Food Chem Toxicol. 2026;207:115827.
    PubMed         Abstract available


    Front Immunol

  37. ZHANG L, Ai C, Yu S, Li K, et al
    Successful sequential chemo-immunotherapy and reduced-volume brachytherapy for bulky residual cervical tumor after external beam radiotherapy: two case reports.
    Front Immunol. 2025;16:1687247.
    PubMed         Abstract available


    Front Med (Lausanne)

  38. LIU X, Wang W, Zhao Y, Gu X, et al
    SPP1, LYZ, and MCM5: potential diagnostic biomarkers for rheumatoid arthritis and cervical cancer comorbidity.
    Front Med (Lausanne). 2025;12:1693787.
    PubMed         Abstract available


    Front Oncol

  39. MCHUGH DJ, Datta A, Dubec MJ, Buckley DL, et al
    Intra-voxel incoherent motion biomarker repeatability in healthy volunteers and sensitivity to chemoradiotherapy-induced changes in patients with uterine cervical cancer.
    Front Oncol. 2025;15:1633456.
    PubMed         Abstract available

  40. BELDI MC, Colunna FC, Lorenzi NP, Lasso Larco JA, et al
    Uncoupling protein 2 and signal transducer and activator of transcription 1 are targets of human papillomavirus oncoproteins and may be prognostic markers for cervical cancer development.
    Front Oncol. 2025;15:1689058.
    PubMed         Abstract available

  41. HU M, Chen X, Tong X, Hao C, et al
    Case Report: Rapid resolution of malignant acanthosis nigricans following chemotherapy for cervical cancer.
    Front Oncol. 2025;15:1694975.
    PubMed         Abstract available

  42. LIU H, Chang X, Hong Y, Yin H, et al
    Efficacy and safety of anlotinib hydrochloride combined with concurrent radiotherapy in the treatment of locally advanced cervical cancer: a single-arm, single-center, exploratory, phase II clinical study.
    Front Oncol. 2025;15:1662160.
    PubMed         Abstract available


    Front Public Health

  43. YANG Q, Jiang Y, Liu F, Chang L, et al
    Comparative evaluation of two DNA methylation assays for triage of hrHPV E6/E7 mRNA-positive women.
    Front Public Health. 2025;13:1723553.
    PubMed         Abstract available


    Gynecol Oncol

  44. MATSUO K, Lee MW, Friedman EL, Erfani H, et al
    Survival assessment of sentinel lymph node biopsy alone without lymphadenectomy for early cervical cancer in real-world data.
    Gynecol Oncol. 2025;204:174-183.
    PubMed         Abstract available

  45. HOLTZMAN S, Myers E, Havrilesky LJ, Yamada D, et al
    Gynecologic oncology fellowship trends: Supply outpacing demand, geographical maldistribution.
    Gynecol Oncol. 2025;202:162-166.
    PubMed         Abstract available

  46. DRAYER SM, Ogata JD, Cronin S, Tumas J, et al
    Silva pattern-guided proteomics reveals coordinated tumor-stroma remodeling in cervical adenocarcinoma.
    Gynecol Oncol. 2025;202:66-76.
    PubMed         Abstract available

  47. MILMAN T, Hoang L, Hamm J, Chai J, et al
    Real-world utility of Silva pattern in predicting outcomes in cervical adenocarcinoma from a population-based series.
    Gynecol Oncol. 2025;202:53-58.
    PubMed         Abstract available

  48. VAN DEN BORST E, Vanden Broeck D, De Sutter P, Donders G, et al
    EUROArray HPV test accuracy for cervical precancer in self- vs. clinician-collected samples using the VALHUDES protocol.
    Gynecol Oncol. 2025;202:14-23.
    PubMed         Abstract available


    Health Educ Res

  49. CALDERON-MORA J, Molokwu J, Byrd TL, Alomari A, et al
    Program implementation and evaluation of De Casa en Casa: a tailored community-based cervical cancer screening program for underserved Hispanic women.
    Health Educ Res. 2025;40:cyaf055.
    PubMed         Abstract available


    Hell J Nucl Med

  50. LAI R, Sheng D, Geng Y, Ding C, et al
    (18)F-FDG PET based intratumoral and peritumoral explainable radiomics for predicting cervical cancer prognosis: A multi-center retrospective study.
    Hell J Nucl Med. 2025 Dec 15:s002449912907. doi: 10.1967/s002449912907.
    PubMed         Abstract available


    Hum Vaccin Immunother

  51. BAE S, Park JH, Oh S, Yang G, et al
    Public health impact and cost-effectiveness of implementing gender-neutral immunization with the nonavalent human papillomavirus vaccine in South Korea.
    Hum Vaccin Immunother. 2025;21:2582299.
    PubMed         Abstract available

  52. OZDEMIR CY, Marangoz B, Cicekli N, Savas M, et al
    HPV vaccine awareness and vaccination status among women of reproductive age in Turkiye: A cross-sectional study.
    Hum Vaccin Immunother. 2025;21:2586826.
    PubMed         Abstract available


    Indian J Pathol Microbiol

  53. MAJUMDER A, Rekhi B, Mittal N, Menon S, et al
    Carcinosarcoma of the cervix: Clinicopathological features of 17 tumors diagnosed at a Tertiary Cancer Referral Centre, India.
    Indian J Pathol Microbiol. 2025;68:744-753.
    PubMed         Abstract available


    Inflamm Res

  54. ZHANG Q, Tang H, Shen W, Gao J, et al
    LncRNA TYMSOS stimulates immune escape and the advancement of cervical squamous cell carcinoma by regulating miR-134-5p/KRAS expression.
    Inflamm Res. 2025;75:3.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  55. MANISHA M, Singh P, Yadav G, Gothwal M, et al
    Genotype-specific Human Papillomavirus patterns and their implications across the cervical cancer spectrum: A cross-sectional study from Western India.
    Int J Gynaecol Obstet. 2025 Dec 12. doi: 10.1002/ijgo.70730.
    PubMed         Abstract available


    Int J Gynecol Cancer

  56. PAN TL, Friko I, Mwinbe-Ere Der V, Gultekin M, et al
    Building cervical cancer screening capacity in low-resource settings: lessons from Techiman, Ghana.
    Int J Gynecol Cancer. 2025 Nov 28:102808. doi: 10.1016/j.ijgc.2025.102808.
    PubMed        

  57. CONZUELO RODRIGUEZ G, Cremer ML, Soler M, Alfaro K, et al
    Long-term impact of cervical ablation in visual assessment of the squamocolumnar junction: implications for subsequent screening and follow-up.
    Int J Gynecol Cancer. 2025;35:102717.
    PubMed         Abstract available


    Int J Oncol

  58. YE H, Zhang Y, Geng L, Li Z, et al
    [Retracted] Cdc42 expression in cervical cancer and its effects on cervical tumor invasion and migration.
    Int J Oncol. 2026;68:20.
    PubMed         Abstract available


    Int J Surg

  59. ZHANG S, Wang F, Yang H, Wang L, et al
    Uterine manipulator-free minimally invasive surgery for early-stage cervical cancer: a step toward oncologic safety.
    Int J Surg. 2025 Dec 8. doi: 10.1097/JS9.0000000000004269.
    PubMed        

  60. ZHANG L, Chen W, Hou Y, Gao P, et al
    Incidence, prevalence, deaths, and DALYs of diseases of the female reproductive system from 1990 to 2021 across 204 countries: data, with critical re-analysis, from the global burden of disease study.
    Int J Surg. 2025;111:9166-9177.
    PubMed         Abstract available


    Iran J Public Health

  61. MALIAKKAL BABU JS, Subashini P, Dhivyaprabha TT
    Advancing Cervical Cancer Care: A Comprehensive Study of Screening Approach for Tribal Women in Sub-Saharan Africa and Asia.
    Iran J Public Health. 2025;54:2151-2160.
    PubMed         Abstract available


    J Am Soc Cytopathol

  62. MARSDEN KA, Wilkinson ZA, Dyhdalo KS, Hoda RS, et al
    Acidic alterations: impact of glacial acetic acid treatment on interpretations of atypical endocervical and atypical glandular cells, not otherwise specified in Pap tests.
    J Am Soc Cytopathol. 2025;14:428-433.
    PubMed         Abstract available

  63. JONES TE, Zeng X, Matsko J, Harinath L, et al
    The clinical significance of atypical glandular cells in Papanicolaou tests: changes in diagnostic patterns over 15 years at a single institution.
    J Am Soc Cytopathol. 2025;14:434-443.
    PubMed         Abstract available


    J Cancer Educ

  64. MAGONDU W, Ochola S, Rucha K
    Effects of Educational Intervention on Uptake of Cervical Cancer Preventive Services at Kenyatta University, Kenya; A Cluster Randomized Control Trial.
    J Cancer Educ. 2025 Dec 13. doi: 10.1007/s13187-025-02797.
    PubMed         Abstract available


    J Coll Physicians Surg Pak

  65. ZHAO X, Zhang J, Xia Y, Liu S, et al
    Diagnostic Efficacy of Serum PDCD4 and HSP70 Levels for Lymph Node Metastasis in Early Cervical Cancer.
    J Coll Physicians Surg Pak. 2025;35:1568-1573.
    PubMed         Abstract available


    J Control Release

  66. HUA Y, Xu Y, Wan J, Fan Y, et al
    A dual-responsive AI-designed peptide P9-conjugate disrupts E6-E6AP Interface to restore p53 and suppress HPV16-driven cervical cancer.
    J Control Release. 2025 Dec 11:114536. doi: 10.1016/j.jconrel.2025.114536.
    PubMed         Abstract available


    J Ethnopharmacol

  67. DANG S, Tang X, Li Q, Wu J, et al
    Xiao-Liu Tang (XLT), a traditional Chinese medicine formula that suppresses the progression of cervical cancer by inducing apoptosis and inhibiting cell migration.
    J Ethnopharmacol. 2025;358:120966.
    PubMed         Abstract available


    J Gynecol Oncol

  68. HU L, Li J, Du Y, Mei F, et al
    Lobaplatin versus cisplatin in concurrent chemoradiotherapy for elderly cervical cancer: randomized controlled phase II study.
    J Gynecol Oncol. 2025 Nov 21. doi: 10.3802/jgo.2026.
    PubMed         Abstract available


    J Med Virol

  69. OLTHOF EMG, van den Brule AJC, Melchers WJG, Berkhof J, et al
    Improving Efficiency in Dutch Cervical Screening by Genotyping: An Analysis of Real World Program Data.
    J Med Virol. 2025;97:e70745.
    PubMed         Abstract available

  70. LI Q, Cao Y, Yu Y, Zhang Y, et al
    Cervical/Anal HPV-Cytology Concordance With Colposcopic-Anoscopic Pathology: 984 Women Without HIV in China's Largest Lower Genital Tract Center.
    J Med Virol. 2025;97:e70710.
    PubMed         Abstract available

  71. LIU H, Zhou J, Xiao Y, Zheng Y, et al
    High-Throughput Targeted Sequencing Identifies an HPV Methylation Panel for Detecting Cervical Lesion Progression.
    J Med Virol. 2025;97:e70739.
    PubMed         Abstract available

  72. SCOTT H, Stevenson A, Mair D, Rooney WM, et al
    Viability of Self-Taken Vaginal Swab Samples for RNA-Based Biomarker Analysis in Cervical Disease.
    J Med Virol. 2025;97:e70737.
    PubMed         Abstract available


    J Natl Cancer Inst

  73. HAAS JS, Todd KW, Mclerran D, Tiro JA, et al
    Gaps in care across the cancer screening continuum for cervical, colorectal and lung cancer.
    J Natl Cancer Inst. 2025 Sep 10:djaf248. doi: 10.1093.
    PubMed         Abstract available


    J Obstet Gynaecol

  74. ZHAN Q, Xu N, Fan J, Wang J, et al
    Prognostic value of systemic immune-inflammation index in cervical cancer: a systematic review and meta-analysis.
    J Obstet Gynaecol. 2025;45:2601171.
    PubMed         Abstract available


    J Pathol

  75. PAVILION G, Vu H, Xiong Z, Dang TVT, et al
    Spatial analysis of HPV-associated cervical intraepithelial neoplastic tissues demonstrate distinct immune signatures associated with cervical cancer progression.
    J Pathol. 2025 Dec 9. doi: 10.1002/path.70002.
    PubMed         Abstract available


    JAMA

  76. PANT S
    Strides in Cervical Cancer Elimination.
    JAMA. 2025 Dec 12. doi: 10.1001/jama.2025.20021.
    PubMed        


    JAMA Netw Open

  77. SHIN MB, Axeen S, Cole AM, Guo XM, et al
    Nonadherence to Cervical Cancer Screening Guidelines in Commercially Insured US Adults, 2013-2021.
    JAMA Netw Open. 2025;8:e2548512.
    PubMed        


    JCO Glob Oncol

  78. QURIESHI MA, Haq I, Malik TZ, Ahmad SZ, et al
    Association Between Male Circumcision and Cervical Cancer Risk: A Systematic Review and Meta-Analysis of Analytical Studies.
    JCO Glob Oncol. 2025;11:e2500126.
    PubMed         Abstract available


    JMIR Public Health Surveill

  79. ABUZOOR A, Jabin MSR, Eshareturi C, Nesbitt R, et al
    Using the Health Belief Model to Examine Parental Knowledge and Health Beliefs About Human Papilloma Virus (HPV) and iHPV Vaccine in Kuwait: Cross-Sectional Survey Study.
    JMIR Public Health Surveill. 2025;11:e75818.
    PubMed         Abstract available


    Kaohsiung J Med Sci


  80. Correction to "Circular RNA circRNA_101996 Promoted Cervical Cancer Development by Regulating miR-1236-3p/TRIM37 Axis".
    Kaohsiung J Med Sci. 2025 Dec 5:e70151. doi: 10.1002/kjm2.70151.
    PubMed        


    Kyobu Geka

  81. NISHIYAMA M, Okada T, Uetsuki T, Jinzai Y, et al
    [Surgical Resection of Metastatic Cardiac Tumors].
    Kyobu Geka. 2025;78:1082-1087.
    PubMed         Abstract available


    Lancet Digit Health

  82. GICHOYA JW, Mwavu R, Minja F, Kaonga N, et al
    Leveraging digital technologies to reduce cancer disparities in low-income and middle-income countries.
    Lancet Digit Health. 2025;7:100937.
    PubMed         Abstract available


    Lancet Glob Health

  83. BARRETT C, Joseph JT, Horning MP, Anne M, et al
    Performance of an artificial intelligence-based tool for cervical precancer screening in five countries in Africa: a prospective, observational, diagnostic accuracy study.
    Lancet Glob Health. 2026;14:e49-e60.
    PubMed         Abstract available


    Med

  84. HOW JA, Jazaeri AA
    Photodynamic therapy: An alternative technique to cervical conization for cervical dysplasia.
    Med. 2025;6:100922.
    PubMed         Abstract available

  85. CHEN F, Hillemanns P, Ruan H, Chen X, et al
    Photodynamic therapy for high-grade squamous intraepithelial lesions: A randomized controlled trial.
    Med. 2025;6:100851.
    PubMed         Abstract available


    Med Eng Phys

  86. SINGH S, Sahu C, Singh P, Mishra A, et al
    Refining cell classification for cervical cancer detection using an improved high dimensional feature fusion approach.
    Med Eng Phys. 2025;146:104445.
    PubMed         Abstract available


    Medicine (Baltimore)

  87. WANG H, Zhang J, Li J, Sun B, et al
    Expression of ACTR3 in cervical cancer and impact on immune cell infiltration and prognosis: A comprehensive analysis based on bulk RNA-Seq and single-cell RNA-Seq.
    Medicine (Baltimore). 2025;104:e46316.
    PubMed         Abstract available


    Molecules

  88. LEVENTIC M, Matic J, Pavlovic Saftic D, Ban Z, et al
    Molecular Pathways Affected by Sulfonylpurine Derivatives in 2D and 3D HeLa Cell Models.
    Molecules. 2025;30:4659.
    PubMed         Abstract available


    NMR Biomed

  89. HAMILTON G, Gamboa NA, Schlein AN, Ebrahimi S, et al
    Multi-Parameter Magnetic Resonance Spectroscopy in Cervix.
    NMR Biomed. 2026;39:e70211.
    PubMed         Abstract available


    NPJ Precis Oncol

  90. FENG Y, Sun Z, Li Y, Wang F, et al
    A machine learning-based framework for prognostic prediction and tumor microenvironment characterization of locally advanced cervical cancer with concurrent chemoradiotherapy.
    NPJ Precis Oncol. 2025 Dec 12. doi: 10.1038/s41698-025-01234.
    PubMed         Abstract available


    Nucl Med Commun

  91. HUA Y, Wang B, Su Q
    The relationship between posttreatment 18 F-fluorodeoxyglucose PET/computed tomography restaging and metabolic parameters with the prognosis of uterine cervical cancer.
    Nucl Med Commun. 2025 Dec 12. doi: 10.1097/MNM.0000000000002093.
    PubMed         Abstract available


    O G Open

  92. SANTOS N, Kim J, Hsu K, Gemson E, et al
    Association Between Age and Race and Cervical Cancer Stage.
    O G Open. 2025;2:e138.
    PubMed         Abstract available


    Obstet Gynecol

  93. QIN J, Martinez G, Holt HK, Gopalani SV, et al
    Preferences Among U.S. Women for Cervical Cancer Screening with Self-Collected Specimens for Human Papillomavirus Testing.
    Obstet Gynecol. 2025 Dec 11. doi: 10.1097/AOG.0000000000006147.
    PubMed         Abstract available


    Obstet Gynecol Surv

  94. PRETI M, Lewis F, Carcopino X, Bevilacqua F, et al
    Vulvar Inspection at the Time of Cervical Cancer Screening: European Society of Gynecological Oncology (ESGO), International Society for the Study of Vulvovaginal Disease (ISSVD), European College for the Study of Vulval Disease (ECSVD), and European
    Obstet Gynecol Surv. 2025;80:759-761.
    PubMed         Abstract available


    Oncologist

  95. MOONO M, Sharma A, Bohlius J, Mwanahamuntu M, et al
    The Cervical Cancer Screening and Precancer Treatment Journey: A Qualitative Study of Experiences Among Zambian Women Living With and Without HIV.
    Oncologist. 2025 Dec 13:oyaf412. doi: 10.1093.
    PubMed         Abstract available

  96. PETROS H, Destaw A, Getachew S, Ahmed I, et al
    Prevalence and associated factors of persistent precancerous lesions among women treated for cervical lesions in Addis Ababa, Ethiopia.
    Oncologist. 2025;30:oyaf392.
    PubMed         Abstract available


    Oncology

  97. WANG S, She C, Xu G, Hu X, et al
    A Study on the Improvement of Quality of Survival in Cervical Cancer Patients after Chemoradiotherapy through an Integrated Traditional Chinese and Western Medicine Therapy Based on a Syndrome Differentiation-Driven Dynamic Intervention Strategy.
    Oncology. 2025 Dec 4:1-15. doi: 10.1159/000548661.
    PubMed         Abstract available


    Oncology (Williston Park)

  98. ANDREA I NANEZ MD, Velez MA, Mae Zakhour Md, Garon EB, et al
    Differences in Clinical Trial Availability vs Distribution of Disease Among Gynecological Cancers.
    Oncology (Williston Park). 2025;39:456-462.
    PubMed         Abstract available


    PLoS One

  99. MENGISTIE BA, Aragaw GM, Anteneh TA, Wondie KY, et al
    Prevalence and determinants of precancerous cervical lesions among women screened for cervical cancer in Africa: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0338484.
    PubMed         Abstract available

  100. NESSA A, Ferdouse J, Khatoon F, Sonia AA, et al
    High-risk human papillomavirus genotypes among women of hill districts in Bangladesh.
    PLoS One. 2025;20:e0338092.
    PubMed         Abstract available


    Pract Radiat Oncol

  101. WEIL CR, Brower J, Small W Jr, Gaffney DK, et al
    Immunotherapy in the upfront definitive management of locally advanced cervical cancer: An evolving treatment paradigm.
    Pract Radiat Oncol. 2025 Dec 6:S1879-8500(25)00312.
    PubMed         Abstract available


    Prev Med

  102. ARAGAW FM, Dawson A, Lekkas P, Yeo S, et al
    Cancer screening uptake among refugees in high and middle-income countries: a systematic review.
    Prev Med. 2026;202:108469.
    PubMed         Abstract available


    Quant Imaging Med Surg

  103. QI Y, Chen X, Chi F, Chen Z, et al
    Dosimetric impact of bladder volume variation on online adaptive radiotherapy for cervical cancer based on cone-beam computed tomography and clinical management strategies.
    Quant Imaging Med Surg. 2025;15:12320-12335.
    PubMed         Abstract available


    Regen Biomater

  104. NIE X, Wang L, Yang W, Maimaiti M, et al
    Study on the role and mechanism of magnesium-calcium-mineralized collagen composite scaffolds in the adjuvant treatment of cervical cancer.
    Regen Biomater. 2025;12:rbaf110.
    PubMed         Abstract available


    Rom J Morphol Embryol

  105. DIJMARESCU AL, Camen IV, Manolea MM, Radu M, et al
    Delayed onset of HPV-associated uterine malignancies: seven pathogenetic factors in contrast to cervical cancer.
    Rom J Morphol Embryol. 2025;66:443-451.
    PubMed         Abstract available


    RSC Adv

  106. WANG X, Du L, Xue Y, Su Y, et al
    Design, synthesis and anti-cervical cancer activity of aroylpyrrole-based derivatives as potent histone deacetylase 6 inhibitors.
    RSC Adv. 2025;15:47637-47647.
    PubMed         Abstract available


    Scand J Prim Health Care

  107. BRENNA I, Mjolstad BP, Baasland I, Gilstad H, et al
    Communicating abnormal cervical cancer screening results - a focus group study with general practitioners in Norway.
    Scand J Prim Health Care. 2025 Dec 5:1-13. doi: 10.1080/02813432.2025.2597785.
    PubMed         Abstract available


    Sci Rep

  108. LEE Y, Park SY, Shim BS, Kim B, et al
    miR-193a-5p-mediated Inhibition of the METTL1/COX-2 axis is critical for Astragalin-induced apoptosis in cervical cancer.
    Sci Rep. 2025 Dec 13. doi: 10.1038/s41598-025-32320.
    PubMed         Abstract available

  109. JAIN S, Jain A, Jangid M
    MGWO-CNN: hyperparameter optimization of CNN classifier for cervical cancer detection using Modified Grey Wolf Optimizer.
    Sci Rep. 2025;15:43514.
    PubMed         Abstract available


    Semin Cancer Biol


  110. Expression of concern "Remodeling of tumor microenvironment by cellular senescence and immunosenescence in cervical cancer" [Semin. Cancer Biol. 108 (2025) 17-32].
    Semin Cancer Biol. 2025;117:124.
    PubMed        


    Talanta

  111. HE Y, Zhao M, Zhang H, Ji M, et al
    Deep learning enhanced label-free cervical screening via stimulated Raman cytology.
    Talanta. 2026;298.
    PubMed         Abstract available


    Technol Cancer Res Treat

  112. CAO D, Jin J, Han J, Yang B, et al
    MDA-TransUNet: A Deep Learning-Based Automatic Segmentation Method for Cervical Cancer Brachytherapy.
    Technol Cancer Res Treat. 2025;24:15330338251397035.
    PubMed         Abstract available


    Tissue Cell

  113. CHEN S, Zheng C
    POU6F1 inhibits cervical cancer progression by activating MAOB to block the ERK1/2 pathway.
    Tissue Cell. 2025;99:103257.
    PubMed         Abstract available


    Transl Cancer Res

  114. YANG Q, Zhang J, Shang X, Sun B, et al
    Fatty acid metabolism-related signature suggests an oncogenic role of FASN in cervical cancer.
    Transl Cancer Res. 2025;14:8032-8054.
    PubMed         Abstract available


    Vaccine

  115. PEI C, Zeng D, He C, Sun W, et al
    A national survey on HPV vaccination status among 42,800 female physicians and nurses in China, 2021.
    Vaccine. 2025;70:128025.
    PubMed         Abstract available

  116. KELLY SA, Changalucha J, Malibwa D, Ewing VL, et al
    Knowledge and acceptability of male HPV vaccination among young people and community stakeholders in northwest Tanzania: social sciences in the Add-Vacc trial.
    Vaccine. 2025;69:128002.
    PubMed         Abstract available

  117. DOULOU K, Bacopoulou F, Michos A, Tsolakidis A, et al
    HPV vaccination coverage among children and adolescents in Greece using national prescription data.
    Vaccine. 2025;70:128026.
    PubMed         Abstract available

  118. NJOH AA, Bolio A, Venczel L, Libwea JN, et al
    Key players and determinants improving human papillomavirus vaccination coverage in Cameroon: a cross-sectional nationwide health workers survey.
    Vaccine. 2025;69:128006.
    PubMed         Abstract available


    Virol J

  119. TAHIR M, Mohammed D, Sadiq C
    Prevalence and genotypic characterization of human papillomavirus in Iraqi women: a retrospective study of 2,193 cases.
    Virol J. 2025;22:394.
    PubMed         Abstract available

  120. LUO X, Chen Y, He L, Liu S, et al
    HPV genotype distribution and cervical lesion severity in HPV-positive women: a study from the Guizhou Province cervical cancer screening program.
    Virol J. 2025 Dec 9. doi: 10.1186/s12985-025-03041.
    PubMed         Abstract available


    World J Psychiatry

  121. SUN QQ, Ke FF, Zhou HY, Zhou SJ, et al
    Mindfulness-based stress reduction for sexual psychological recovery after radical cervical cancer surgery: A retrospective study.
    World J Psychiatry. 2025;15:112655.
    PubMed         Abstract available

  122. MA J, Xu H, Yang B, Han X, et al
    Construction of a psychological intervention program to support fear of recurrence in patients with cervical cancer.
    World J Psychiatry. 2025;15:112651.
    PubMed         Abstract available

  123. XIE ZJ, Zhang H, Ma RY, Su HL, et al
    Influencing factors and predictive model construction of anxiety and depression in patients with cervical cancer.
    World J Psychiatry. 2025;15:111761.
    PubMed         Abstract available


    World J Surg Oncol

  124. LI B, Fu Y, Wang R, Wang Q, et al
    miR-338-3p targets WAPL to suppress proliferation and invasion in cervical cancer cells: experimental insights.
    World J Surg Oncol. 2025 Dec 7. doi: 10.1186/s12957-025-04125.
    PubMed         Abstract available


    Zhonghua Bing Li Xue Za Zhi

  125. TENG XL, Ran CH, Ding CX, Zhang JJ, et al
    [SMARCA4-deficient tumors of the female reproductive system: a clinicopathological analysis of five cases].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:1338-1340.
    PubMed        

  126. ZHAO J, Luo RK, Zhang LL, Gu WY, et al
    [Atypical forms of microglandular hyperplasia of the cervix: a clinicopathological analysis of 29 cases].
    Zhonghua Bing Li Xue Za Zhi. 2025;54:1311-1316.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.